The company will offer Ventis Pharma’s patented local anesthetic compound, Endura-KitTM for post-operative surgical and chronic pain management
This certification paves the way for CORONA's entry into five EAEU member nations- Russia, Kyrgyzstan, Armenia, Belarus, and Kazakhstan-under a B2B business model
Sabitha highlighted the growing relevance of minimally invasive therapies in modern medicine
Provides pain relief for more than 30 conditions, including chronic back pain, arthritis, and sports injuries
DUPLEX’s two-compartment, PVC- and DEHP-free design keeps medication and diluent separate until activation
Senores Pharmaceuticals is poised to accelerate its presence in the Asia-Pacific region
Grant of Permission to manufacture and market FDC of Naproxen Delayed Release and Esomeprazole capsule (375mg/500mg + 20mg/20mg)
EBITDA stood at Rs. 100.1 crore with a margin of 16.1 per cent
The company reported revenue from operations at Rs. 6,573.7 crore, up 6 per cent YoY
The performance was below anticipated levels, primarily due to external factors such as seasonal disruption that affected overall results
Subscribe To Our Newsletter & Stay Updated
